Literature DB >> 2713852

Stimulation of growth in human and murine cells by adriamycin.

P Vichi1, T R Tritton.   

Abstract

Adriamycin causes a variety of biological actions and is an effective cytotoxic agent against proliferating cells. In this paper we show that the drug is not limited in its action solely to cytotoxicity, but can also stimulate cell growth under the appropriate conditions. Using the survival assay of cloning in soft agar, we present data showing that the conditions for Adriamycin-induced growth stimulation are that the drug be in a subtoxic concentration range of 10(-10)-10(-9) M (greater than 10(-8) M causes cytotoxicity) and that the growth medium be suboptimal. This latter condition is satisfied by either growing cells for an extended period in order to exhaust the growth supporting capacity of the medium, or by growing the cells at low (less than 10%) serum concentrations. Several active anthracycline congeners also have the ability to stimulate growth. The results indicate that the cytotoxic anticancer agent Adriamycin can stimulate the proliferation of some cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713852

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

Authors:  J S Damiano; A E Cress; L A Hazlehurst; A A Shtil; W S Dalton
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  An ethics of expertise based on informed consent.

Authors:  Kevin C Elliott
Journal:  Sci Eng Ethics       Date:  2006-10       Impact factor: 3.525

3.  Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery.

Authors:  Jun Chen; Sithira Ratnayaka; Aaron Alford; Veronika Kozlovskaya; Fei Liu; Bing Xue; Kenneth Hoyt; Eugenia Kharlampieva
Journal:  ACS Nano       Date:  2017-03-10       Impact factor: 15.881

4.  Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?

Authors:  D J Morré; C Kim; M Paulik; D M Morré; W P Faulk
Journal:  J Bioenerg Biomembr       Date:  1997-06       Impact factor: 2.945

5.  [Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)].

Authors:  S Sertel; T Eichhorn; P K Plinkert; T Efferth
Journal:  HNO       Date:  2011-12       Impact factor: 1.284

Review 6.  Hormesis as a biological hypothesis.

Authors:  E J Calabrese; L A Baldwin
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 7.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

8.  Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment.

Authors:  O Pauwels; R Kiss
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Chemosensitivity testing of small cell lung cancer using the MTT assay.

Authors:  B G Campling; J Pym; H M Baker; S P Cole; Y M Lam
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.

Authors:  M Lohmeyer; P Workman
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.